Mentor joins bidding war with offer to acquire Medicis

Mentor has offered $2.2 billion in stock to buy Medicis in a bid to emerge as a dominant player in the cosmetic drug business. Santa Barbara, CA-based Mentor makes urological products. But Medicis immediately rejected the offer, instead reaffirming its own bid to buy the breast implant maker Inamed. Allergan, which makes Botox, has also made a bid to buy Inamed.

- read this report from MarketWatch for more

Suggested Articles

Loretta Itri, M.D. has been helping Immunomedics out with its troubled antibody-drug conjugate. Now, she’s signing on as its chief medical officer.

Light Chain Bioscience, a unit of Swiss biotech Novimmune, has been handed a nice royalty milestone check from partner Takeda.

The fund received money from Chinese organizations inside and outside the biopharma industry, enabling CICC Capital to ease past its financing goal.